Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2008
11/12/2008CN101302246A Melanin cortical hormone receptor heptapeptide excitant, preparation and use thereof
11/12/2008CN100432098C Antigen epitope I of B cell of chicken IBDV VP3 protein
11/11/2008US7449551 PRO211 polypeptides
11/11/2008US7449545 Antimicrobial bolisin peptides
11/11/2008US7449447 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
11/11/2008US7449445 Conductive peptide nanofiber and method of manufacture of the same
11/11/2008US7449191 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
11/06/2008WO2008133908A2 Suspension formulations of insulinotropic peptides and uses thereof
11/06/2008WO2008131951A1 Selective targeting of viruses to neural precursor cells
11/06/2008WO2008131599A1 T-cell receptor vaccines materials and methods
11/06/2008WO2008131508A1 Analgesic compounds
11/06/2008WO2008076824A3 Therapeutic and diagnostic peptides
11/06/2008WO2008073174A3 Antimicrobial therapy
11/06/2008WO2006046978A3 Cationic peptide-mediated transformation
11/06/2008US20080275216 Fluorous Capping Reagents and Methods for Peptide Purification
11/06/2008US20080275214 Viral peptides for use in activating immune response to treat and prevent viral infection
11/06/2008US20080275017 Aromatic sulfenates for type i phototherapy
11/06/2008US20080274980 Macromonomers and hydrogel systems using native chemical ligation, and their methods of preparation
11/06/2008US20080274978 Tryptophan rich mimics; antiinflammatory agents; drug screening for formyl peptide receptor like 1 (FPRL1) activity; arthritis, autoimmune disorders, Alzheimer's disease
11/06/2008US20080274977 Treating stroke and other diseases without inhibiting N-type calcium channels
11/06/2008US20080274975 Human A beta binding alcohol dehydrogenase (ABAD) inhibitors; amino acid sequence 94-114 of ABAD; Alzheimer's disease; reducing free radical generation, DNA fragmentation and cytochrome C cellular release; preserving cell viability
11/06/2008US20080274961 Respiratory system disorders; lung hypotensive agents; also pituitary adenylate cyclase activated peptide
11/06/2008US20080274956 Fusion Protein Comprising a Bh3-Domain of a Bh3-Only Protein
11/06/2008US20080274952 Therapy for metabolism disorders; obesity; diabetes; cardovascular disordrs; eating disorders; hypoglycemic agents; hypotensive agents; dyslipidemia; sleep disorders; respiraotry system disorders; osteoarthritis; insulin resistance
11/06/2008US20080274508 Expression system for enhancing solubility and immunogeneicity of recombinant proteins
11/06/2008US20080274128 Heat shock protein-based vaccines and immunotherapies
11/06/2008US20080274112 Axonal growth receptor for use in designing immunoglobulins for prevention and treatment of nervous system, cardiovascular, vision and/or spinal cord injury
11/06/2008US20080274052 [18F]-fluorination for use making radiopharmaceuticals for Positron Emission Tomography (PET); reacting a compound of formula 18F-(Linker)-SH with an activated peptide
11/06/2008CA2685720A1 Analgesic compounds
11/05/2008EP1988163A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
11/05/2008EP1987178A2 Method of constructing and screening libraries of peptide structures
11/05/2008EP1987057A2 Peptide aptamer for neutralizing the binding of platelet antigene specific antibodies and diagnostic and therapeutic applications containing the same
11/05/2008EP1987055A1 Novel antimicrobial peptides and use thereof
11/05/2008EP1987052A1 Synthesis of glucagon-like peptide
11/05/2008EP1696944A4 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
11/05/2008EP1488364B1 Method and system to build optimal models of 3-dimensional molecular structures
11/05/2008EP0994724B1 Methods and compositions for impairing multiplication of hiv-1
11/05/2008CN101298472A Growth inhibition hormone peptide derivatives and preparation thereof
11/05/2008CN101298471A Epitope capable of exciting human body anti-mycobacterium tuberculosis protective immunity reaction and use thereof
11/05/2008CN100430727C Assaying protein fragments in body fluids
11/04/2008US7446120 (3mercapta-1,2,4-triazole-5yl)-phenyl-tertbutane; cadherin cell adhesion recognition sequence His-Ala-Val within a cyclic peptide ring; enhance drug delivery to cells in need (tumor, Schwann cells, oligodendrocytes, graft rejection, epidermal patches); anticarcinogenic, angiogenesis inhibitor
11/04/2008US7446095 Peptides modulating caspase activation
11/04/2008US7446092 Glycogen synthase kinase-3 inhibitors
11/04/2008US7445905 Contacting cells with receptor and determining formation of complexes; modulating gene expression in acinar cells of pancreatitis associated protein
11/04/2008US7445788 Polypeptide for use in the diagnosis and detection of bacterial infections
11/04/2008US7445784 Apoptosis of rectum and prostate cancer
11/04/2008CA2362481C Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/04/2008CA2223432C Radiometal-binding analogues of luteinizing hormone releasing hormone
10/2008
10/30/2008WO2008131014A1 Lipopeptides and lipopeptide synthetases
10/30/2008WO2008130217A1 Cyclic angiotensin analogs
10/30/2008WO2008128456A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/30/2008WO2008073312A3 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
10/30/2008WO2008070049A8 Peptide and treatment for hiv-1 infection
10/30/2008WO2008057709A3 Sol-gel materials for cellular modulation
10/30/2008WO2007096662A9 Cancer imaging and treatment
10/30/2008US20080269139 FGF-5 Supported and Binding Peptides
10/30/2008US20080269138 Selectively bind DNA and entering nucleus of cells; for modulating gene expression in cells
10/30/2008US20080269136 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
10/30/2008US20080269115 Immunogenic Sars Domain
10/30/2008US20080268474 Prion protein ligands and methods of use
10/30/2008US20080268470 Methods of selecting cell clones
10/30/2008US20080268029 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases
10/30/2008US20080268015 Methods and compositions for promoting localization of pharmaceutically active agents to bone
10/30/2008US20080267986 Using beta amyloid antigenic fragment to produce vaccine for prevention and treatment of autoimmune, nervous system and diabetic disorders
10/30/2008US20080267983 Mimetic peptide for use in treatment and prevention of stroke, cardiovascular, neurodegenerative, inflammatory and vision defects
10/30/2008US20080267882 Multimeric RGD (arginine-glycine-aspartic acid (Arg-Gly-Asp)) peptide; positron emission tomography; angiogenesis; kits
10/30/2008US20080267881 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
10/30/2008US20080267872 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
10/30/2008CA2690772A1 Novel peptide amphiphiles having improved solubility and methods of using same
10/30/2008CA2685185A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985708A1 Selective targeting of viruses to neural precursor cells
10/29/2008EP1985625A2 Synthetic peptide constructs for the diagnosis and treatment of periodontitus associated with porphyromonas gingivalis
10/29/2008EP1985624A2 Single step method of radiofluorination of biologically active compounds or biomolecules
10/29/2008EP1984741A2 Antibiotics and methods for producing them.
10/29/2008EP1984387A1 New polypeptides kxk and their use
10/29/2008EP1984386A1 Methods for the synthesis of two or more dicarba bridges in organic compounds
10/29/2008EP1710251B1 Novel peptide, process for producing the same and pharmaceutical composition containing the peptide
10/29/2008EP1156823B1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
10/29/2008EP1066390B1 Methods of cancer diagnosis using a chimeric toxin
10/29/2008EP0898580B3 Methods and means for inhibition of cdk4 activity
10/29/2008EP0846128B1 Antimicrobial cationic peptides and methods of screening for the same
10/29/2008CN101296939A Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the same
10/29/2008CN101296938A Production method of colistin rough material powder
10/29/2008CN101293917A Polypeptide combinative with PKR kinase structure field specificity and uses thereof
10/29/2008CN101293916A Monoclone antibody with combined function epiposition, specificity of osteopontin and uses thereof
10/28/2008US7442783 Natural IgM antibodies and inhibitors thereof
10/28/2008US7442769 Antifreeze proteins from basidiomy cetes
10/28/2008US7442763 Kidney diseases
10/28/2008US7442683 For use as antifungal agent
10/28/2008US7442513 Method of screening for agents that modulate a homer signaling pathway
10/28/2008CA2367003C Peptides useful in treating multiple sclerosis and a pharmaceutical composition comprising the same
10/27/2008CA2586748A1 Agents for prophylaxis or treatment of neurological diseases and conditions
10/27/2008CA2585247A1 Agents for prophylaxis or treatment of neurological related diseases and conditions
10/23/2008WO2008127642A1 Myelin specific ige unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis
10/23/2008WO2008127066A1 Peptide inhibitors of receptor activator of nf-kb, and pharmaceutical composition including the same
10/23/2008WO2008126413A1 Tem8 peptides and vaccines comprising the same
10/23/2008WO2008125800A2 Mmp activated vascular disrupting agents
10/23/2008WO2008125464A1 Compounds for the diagnosis of diseases associated with vcam expression
10/23/2008WO2008125420A2 Compounds for diagnosing apoptosis
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 423